Aurobindo Pharma reported INR12.49B in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Cipla INR 9.77B 6.21B Dec/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Hindustan Unilever INR 33.71B 140M Sep/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
UPL INR 16.06B 1.72B Dec/2025